Our Vision

To engineer novel acoustically responsive materials to create better tools to answer today’s clinical challenges.

Our Mission

The TRUST team works very closely together to discover, formulate, validate and develop new clinically impactful translational theranostic applications. We have developed 3 dominant basic platforms to achieve our goal: non-destructive silica encapsulation of enzymes, bioresponsive microbubbles, and stable low boiling-point perfluorocarbon emulsions and are applying them to impactful clinical theranostic applications outlined on our website.

About Us

The Translational Research in Ultrasound Theranostics (TRUST) program develops and translates new generation of theranostic agents to diagnose and/or treat disease, specifically cancer. Our multidisciplinary team is led by 2 basic and 1 clinician scientists and is supported by outstanding and motivated graduate students, postdocs, and research staff with expertise in chemistry, formulation, ultrasound-sensitive materials, gene delivery, engineering and biology.